Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
What the market is pricing into C3ai AI ahead of earnings C3ai Misses EPS Estimates by 345 STNG Scorpio beats Q1 earnings by 166 percent but shares fall 214 percent as investors eye risks ahead Bain Cap GSS BCSS Stock Ceiling Levels Flirts with Breakout 20260420 Align ALGN Stock Strengths and Weaknesses Market Focus 20260420 NET Power NPWR Stock Rating Change Slight Dip 20260420 CWH CampingWorld reports narrower Q1 2026 loss than analyst estimates but stock drops 525 today WHWK Whitehawk Therapeutics reports far wider than expected Q4 2025 loss with shares edging 05 lower today SmartFinancial SMBK Volatility Analysis SmartFinancial posts 14 EPS beat vs analyst consensus estimates Is Athene ATHS stock underperforming Gainers and Losers NLC India MCX and Kaynes Technology Lead Market Movers on Thursday Lightwave Logic LWLG Drops 345 Key Support at 1063 20260519 Polestar PSNY Q4 2024 Earnings Miss EPS 3210 vs 688 Expected NACCO Industries NC Rallies 074 as Bulls Target 5154 20260514 SSRM Q1 2026 Earnings Substantial EPS Beat Surprises Market Stock Slides Nvidia Posts 85 Revenue Surge Yet Keeps China Out of Forward Guidance Pension Payout Decision Lump Sum vs Monthly Payments for Retirees Li Auto Stock Holds Steady Near Midpoint of Key Support and Resistance Levels CATY Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction Clean Harbors CLH Q1 2026 Earnings Earnings Beat Estimates Stock Advances PACB Q1 2026 Earnings Narrowerthanexpected loss drives positive market reaction CTNM Q1 2026 Earnings Narrower Loss Beats Estimates as PreRevenue Biotech Maintains Discipline COFS Q1 2026 Earnings Earnings Beat Estimates as EPS Surpasses Consensus Blackrock MuniYield Quality Fund III Inc MYI Posts Modest Gain Holding Near Resistance Power Solutions International PSIX Declines Amid Sector Headwinds Key Support Levels Eyed Anixa Biosciences ANIX Holds Steady at 273 as Consolidation Continues Enliven Therapeutics ELVN Pulls Back 263 as Resistance Holds Support Levels in Focus